Morr F 10% Minoxidil and Finasteride Topical Solution 60ml

Morr F 10% Solution is used to treat alopecia (hair loss). It stimulates hair growth and slows down the process of balding. Morr F 10% Solution is used to promote hair growth in androgenetic alopecia (male pattern hair loss). Androgenetic alopecia is the permanent hair loss from the scalp that causes baldness.

Morr F 10% Solution contains Minoxidil and Finasteride. Minoxidil widens the blood vessels and helps provide oxygen, blood, and nutrients to the hair follicles. Finasteride reduces dihydrotestosterone (male hormone) levels, thereby preventing thinning of hair follicles.

Morr F 10% Solution may cause side effects like unwanted non-scalp hair growth, headache, skin irritation, itching, and dermatitis (itchy inflammation of the skin). If any of these side effects persist or worsen, please consult your doctor or pharmacist for further advice.

Do not use Morr F 10% Solution if you are allergic to any of its components. Do not apply Morr F 10% Solution on shaved, inflamed, infected, irritated or painful scalp skin. Morr F 10% Solution is intended for use by men only and must not be used by women, particularly during pregnancy or breastfeeding.

Key Ingredients

Minoxidil (10% W/V), Finasteride (0.1% W/V)

Uses of Morr F 10% Solution

Morr F 10% Solution is used in the treatment of hair loss in men. The detailed uses of Morr F 10% Solution are as follows:

• Treatment of androgenetic alopecia: Morr F 10% Solution reduces hair loss and stimulates new hair growth in male pattern baldness.
• Promotes hair regrowth: Minoxidil promotes hair regrowth by widening blood vessels and improving blood flow to hair follicles.
• Reduces scalp DHT levels: Finasteride reduces dihydrotestosterone (DHT) locally, a significant factor in hair follicle atrophy and hair loss.
• Improves hair density: Regular use may result in more and thicker hair strands on the scalp.
• Maintains existing hair: Morr F 10% Solution preserves present hair follicles, preventing further thinning.